• In Q1 2026, POET Technologies reported revenue growth of over 200% while contending with multiple class action lawsuits, a CEO departure, and a US$400 million dilutive equity offering.
• This surge in sales, tied to ramping 800G production in Malaysia and a Lumilens order that could become recurring, highlights how operational execution is influencing perceptions despite legal and leadership headwinds.
• Next, we’ll examine how this very large revenue increase and Malaysia 800G ramp shape POET Technologies’ investment narrative amid recent share price declines.

Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

What Is POET Technologies' Investment Narrative?

For POET Technologies to make sense in a portfolio, you really have to buy into the idea that its optical interposer platform can turn early revenue traction into a meaningful, defensible business as high-speed data center demand evolves. The recent quarter’s very large revenue jump, tied to the Malaysia 800G ramp and the Lumilens order, reinforces that execution on the product roadmap remains the key short term catalyst, even as the share price has pulled back sharply. At the same time, the US$400 million equity raise, ongoing class actions, and CEO departure have clearly raised the bar on what the company needs to deliver to justify continued dilution and its current valuation. In that context, this news feels material because it suggests the core operating story is improving while capital structure and legal risks are increasing.

However, one particular financing and governance issue now sits front and center for existing shareholders. The analysis detailed in our POET Technologies valuation report hints at an inflated share price compared to its estimated value.

Exploring Other Perspectives

Seven Simply Wall St Community fair value estimates span roughly US$0.69 to US$17.50, showing wide disagreement on POET’s worth. Set against the recent heavy dilution and unresolved lawsuits, that spread underlines how differently people are weighing execution risk versus optical growth potential.

Explore 7 other fair value estimates on POET Technologies - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your POET Technologies research is our analysis highlighting 1 key reward and 5 important warning signs that could impact your investment decision.
• Our free POET Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate POET Technologies' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our top stock finds are flying under the radar-for now. Get in early:

• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.